- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/415 - 1,2-Diazoles
Patent holdings for IPC class A61K 31/415
Total number of patents in this class: 4032
10-year publication summary
|
227
|
268
|
226
|
256
|
232
|
223
|
186
|
240
|
240
|
141
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2183 |
58 |
| The Regents of the University of California | 20868 |
53 |
| Novartis AG | 10174 |
42 |
| Bristol-myers Squibb Company | 4757 |
42 |
| Arena Pharmaceuticals, Inc. | 343 |
30 |
| Vanderbilt University | 2030 |
30 |
| Merck Sharp & Dohme LLC | 3734 |
29 |
| Allergan, Inc. | 2155 |
28 |
| University of Southern California | 2142 |
26 |
| Laboratorios Del Dr. Esteve, S.A. | 143 |
26 |
| Epizyme, Inc. | 360 |
24 |
| Janssen Pharmaceutica N.V. | 3150 |
23 |
| Glaxosmithkline LLC | 526 |
22 |
| Takeda Pharmaceutical Company Limited | 2698 |
22 |
| Boehringer Ingelheim International GmbH | 4488 |
20 |
| Warsaw Orthopedic, Inc. | 2748 |
20 |
| Loxo Oncology, Inc. | 84 |
20 |
| Inflazome Limited | 84 |
19 |
| Theravance Biopharma R&D IP, LLC | 360 |
19 |
| Eonhf, Inc. | 45 |
19 |
| Other owners | 3460 |